We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
METC icon
1326
Ramaco Resources Class A
METC
$664M
$3.95M 0.01%
464,250
-313,780
-40% -$3.17M
EXFY icon
1327
Expensify
EXFY
$175M
$3.94M 0.01%
446,002
-308,582
-41% -$3.46M
APAM icon
1328
Artisan Partners
APAM
$2.86B
$3.93M 0.01%
+132,386
New +$4.07M
SNAP icon
1329
Snap
SNAP
$7.6B
$3.92M 0.01%
438,439
-1,641,284
-79% -$16.2M
SOXX icon
1330
iShares Semiconductor ETF
SOXX
$42.7B
$3.9M 0.01%
33,600
+30,606
+1,022% +$3.55M
UHAL icon
1331
U-Haul Holding Co
UHAL
$14.3B
$3.89M 0.01%
+64,618
New +$3.72M
LVRAW
1332
CALL
DELISTED
Levere Holdings Corp. Warrant
LVRAW
$3.87M 0.01%
383,331
TFIN icon
1333
Triumph Financial Inc
TFIN
$1.8B
$3.87M 0.01%
79,098
-78,474
-50% -$4.24M
HCMAW
1334
CALL
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$3.85M 0.01%
374,998
VISN
1335
Vistance Networks Inc
VISN
$2.67B
$3.84M 0.01%
523,031
-2,865
-0.5% -$27.6K
UGP icon
1336
Ultrapar
UGP
$6.71B
$3.83M 0.01%
1,583,260
+275,341
+21% +$689K
GCTS.WS
1337
CALL
GCT Semiconductor Holding Warrants
GCTS.WS
$15M
$3.82M 0.01%
375,000
BYNOW
1338
CALL
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$3.82M 0.01%
371,249
XLV icon
1339
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$3.82M 0.01%
28,100
-17,600
-39% -$2.33M
AWIN
1340
DELISTED
AERWINS Technologies Inc
AWIN
$3.81M 0.01%
3,485
XFINW
1341
CALL
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
$3.8M 0.01%
368,894
FCX icon
1342
CALL
Freeport-McMoran
FCX
$90.2B
$3.8M 0.01%
100,000
-50,000
-33% -$1.75M
ZTO icon
1343
ZTO Express
ZTO
$18.1B
$3.79M 0.01%
141,156
-251,221
-64% -$5.77M
H icon
1344
Hyatt Hotels
H
$18B
$3.79M 0.01%
41,881
-242,261
-85% -$22.2M
TLGA.WS
1345
CALL
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$3.76M 0.01%
369,757
-256,442
-41% -$4.95K
PIAI.WS
1346
CALL
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
$3.76M 0.01%
366,663
SAMAW
1347
CALL
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
$3.74M 0.01%
370,763
TGR.WS
1348
CALL
DELISTED
Kimbell Tiger Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TGR.WS
$3.73M 0.01%
358,423
PDM
1349
Piedmont Realty Trust
PDM
$1.22B
$3.73M 0.01%
+406,878
New +$4.02M
TCOA.WS
1350
CALL
DELISTED
Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
TCOA.WS
$3.73M 0.01%
371,250

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.